Summary:
Chicago Research Center is conducting a investigational 52 week study comparing the combination of dapagliflozin and saxagliptin against sitagliptin (added on to diabetics currently on metformin alone).
Qualified Participants Must:
• Have type 2 diabetes
• Only be taking metformin
• Be taking at least 1500mg of Metformin a day
• Have a A1C >7.5
Qualified Participants May Receive:
All study related care and medicine at no cost. Qualified participants may receive compensation for time and travel.